| Molecular tweezers: concepts and applications J Leblond, A Petitjean ChemPhysChem 12 (6), 1043-1051, 2011 | 156 | 2011 |
| Switchable lipids: conformational change for fast pH‐triggered cytoplasmic delivery W Viricel, A Mbarek, J Leblond Angewandte Chemie International Edition 54 (43), 12743-12747, 2015 | 100 | 2015 |
| Reduction of advanced-glycation end products levels and inhibition of RAGE signaling decreases rat vascular calcification induced by diabetes MR Brodeur, C Bouvet, S Bouchard, S Moreau, J Leblond, D Deblois, ... PloS one 9 (1), e85922, 2014 | 97 | 2014 |
| pH-responsive molecular tweezers J Leblond, H Gao, A Petitjean, JC Leroux Journal of the American Chemical Society 132 (25), 8544-8545, 2010 | 97 | 2010 |
| Co-delivery of miR-181a and melphalan by lipid nanoparticles for treatment of seeded retinoblastoma SN Tabatabaei, RM Derbali, C Yang, R Superstein, P Hamel, JL Chain, ... Journal of Controlled Release 298, 177-185, 2019 | 79 | 2019 |
| Aptamer-based liposomes improve specific drug loading and release K Plourde, RM Derbali, A Desrosiers, C Dubath, A Vallée-Bélisle, ... Journal of Controlled Release 251, 82-91, 2017 | 56 | 2017 |
| Bile acid-based drug delivery systems for enhanced doxorubicin encapsulation: Comparing hydrophobic and ionic interactions in drug loading and release AJ Cunningham, M Robinson, X Banquy, J Leblond, XX Zhu Molecular pharmaceutics 15 (3), 1266-1276, 2018 | 55 | 2018 |
| Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study RM Derbali, V Aoun, G Moussa, G Frei, SF Tehrani, JC Del’Orto, ... Molecular pharmaceutics 16 (5), 1906-1916, 2019 | 54 | 2019 |
| Cationic switchable lipids: pH-triggered molecular switch for siRNA delivery W Viricel, S Poirier, A Mbarek, RM Derbali, G Mayer, J Leblond Nanoscale 9 (1), 31-36, 2017 | 54 | 2017 |
| New pharmaceutical applications for macromolecular binders N Bertrand, MA Gauthier, C Bouvet, P Moreau, A Petitjean, JC Leroux, ... Journal of controlled release 155 (2), 200-210, 2011 | 51 | 2011 |
| Lipopolythioureas: a new non-cationic system for gene transfer J Leblond, N Mignet, C Largeau, MV Spanedda, J Seguin, D Scherman, ... Bioconjugate chemistry 18 (2), 484-493, 2007 | 45 | 2007 |
| Pharmaceutical applications of molecular tweezers, clefts and clips A Mbarek, G Moussa, J Leblond Chain Molecules 24 (9), 1803, 2019 | 41 | 2019 |
| Design, synthesis, and evaluation of enhanced DNA binding new lipopolythioureas J Leblond, N Mignet, L Leseurre, C Largeau, M Bessodes, D Scherman, ... Bioconjugate chemistry 17 (5), 1200-1208, 2006 | 36 | 2006 |
| Lipopolythiourea transfecting agents: Lysine thiourea derivatives J Leblond, N Mignet, C Largeau, J Seguin, D Scherman, J Herscovici Bioconjugate chemistry 19 (1), 306-314, 2008 | 30 | 2008 |
| Comparative gene transfer between cationic and thiourea lipoplexes M Breton, J Leblond, J Seguin, P Midoux, D Scherman, J Herscovici, ... The Journal of Gene Medicine 12 (1), 45-54, 2010 | 28 | 2010 |
| Liposomes as gene delivery vectors for human placental cells L Valero, K Alhareth, J Espinoza Romero, W Viricel, J Leblond, A Chissey, ... Molecules 23 (5), 1085, 2018 | 25 | 2018 |
| DNA complexing lipopolythiourea I Tranchant, N Mignet, E Crozat, J Leblond, C Girard, D Scherman, ... Bioconjugate chemistry 15 (6), 1342-1348, 2004 | 24 | 2004 |
| Switchable lipid provides ph-sensitive properties to lipid and hybrid polymer/lipid membranes V Passos Gibson, M Fauquignon, E Ibarboure, J Leblond Chain, ... Polymers 12 (3), 637, 2020 | 20 | 2020 |
| Purification processes of polymeric nanoparticles: How to improve their clinical translation? SF Tehrani, P Bharadwaj, JL Chain, VG Roullin Journal of Controlled Release 360, 591-612, 2023 | 18 | 2023 |
| Lipopolythiourea/DNA interaction: a biophysical study T Kral, J Leblond, M Hof, D Scherman, J Herscovici, N Mignet Biophysical chemistry 148 (1-3), 68-73, 2010 | 18 | 2010 |
Warren ViricelMablink Bioscience在 mablink.com 的电子邮件经过验证
